Vnitr Lek 2012, 58(11):811-812

Adiponektin ve vztahu k ledvinné dysfunkci u nemocných s diabetes mellitus 2. typu - editorial

V. Teplan
Klinika nefrologie Transplantcentra IKEM Praha, přednosta prof. MUDr. Ondřej Viklický, CSc.

Received: August 22, 2012; Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Teplan V. Adiponektin ve vztahu k ledvinné dysfunkci u nemocných s diabetes mellitus 2. typu - editorial. Vnitr Lek. 2012;58(11):811-812.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fujita H, Morii T, Koshimura J et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocrin Journal 2006; 53: 745-752. Go to original source... Go to PubMed...
    2. Saraheimo M, Forsblom C, Fagerudd J et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 2005; 28: 1410-1414. Go to original source... Go to PubMed...
    3. Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care 2007; 30: 239-244. Go to original source... Go to PubMed...
    4. Yenisecu M, Yilmaz MI, Caglar K et al. Adiponectin level is reduced and inversly correlated with the degree of proteinuria in type 2 diabetic patients. Clin Nephrol 2005; 64: 9-12. Go to original source...
    5. Yenisecu M, Yilmaz MI, Caglar K et al. Blockade of the renin-angiotensin system increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Nephron Clin Pract 2005; 99: 115-121. Go to original source... Go to PubMed...
    6. Teplan V, Schück O, Racek J et al. Asymmetric dimethylarginine and adiponectin after renal transplantation: role of obesity. J Ren Nutr 2008; 18: 154-157. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.